Member Info for neilin62

Certainly no expert, but hope this helps.
Assuming the resolutions all get passed, (no reason to assume otherwise) you will automatically have the new shares in CIZ ( consolidated 500:1 as per the prospectus.
BOU will not exist after the vote.
Neil

Thanks TRA1,
There are a surprising number of papers by Dr Coverley and co authors on this research, in addition to other authors. So i will never even hope to find/read them all. This quote stood out in one of them though.......
"Conclusions. Unexpected and unusual molecular structure of CIZ1b in native plasma has complicated immunoassay design, and delayed translation of this promising biomarker. However, CIZ1b can now be measured using a high-throughput, hospital-friendly sandwich ELISA format, overcoming an important barrier to further clinical development and application of this blood test for early stage lung cancer."
Dr Coverley is clearly a very intelligent person, and this is her life's work.
Your previous comments re shareholding also caught my attention.
You are quite correct in that the big holders are funds etc. In my business, i have had dealings with Finance Yorkshire (now known as Mercia) on a number of occasions, and it is quite telling that they elected to take an equity stake in CIZ, and a fair sized one at that, rather than a purely capital/interest repayment schedule.
Their eligibility criteria requirement for this type of investment means they are expecting a significant return.
Speaking on a purely personal level, I,m not really so interested in what the share price will be on Friday, as it will be influenced by
1.The new listing
2. Day traders buying in and selling immediately
3. Existing holders that just want their money back after such a long time in suspension etc.
I am far more interested in where this is going over a longer term.
Neil

So, i get in tonight and was 5 or so minutes late in joining the webinar, I was sitting here, laptop on my knee, when halfway through, the damn thing overheated (blocked the fan vent with my knee!) and shut down. By the time i registered again to join, i had missed certain parts.
From what i can see on the comments, i think there is a misconception that we are 2 years away from anything. This is not true. What Allan said is that we are fully funded for the program for the next two years - quite a different thing.
As for "not having a product yet", again i think that is incorrect. We already have a test, but we are looking for CE / FDA marking TO COMMERCIALISE it. Also, he did stress the different revenue streams. One being the licensing of our technology. Something that can be done now. In fact i think that this route is already in progress.
Someone mentioned Grail. This is spin out company (sound familiar?) from Illumina.This was one of the companies i was researching last year, as they were due to IPO on the market around the time we were speculating about the possible target, and issued a prospectus for $100millioin. As it turned out, the IPO wAs pulled, and Illumina bought their own company back for the sum of $8 BILLION That' a hell of a re-rate. They clearly saw the value . Now, just think, what if sometime in the future they bought us too, given that we are in the same market.
I said we were going into an exciting target, and i am more than happy with what i see. .
This has the potential to be MASSIVE.
Neil

"Shortly after the Acquisition, it is proposed that the group, as enlarged by the Acquisition (the “Enlarged Group”) will enter into agreements with selected manufacturers and contract research organisations to conduct the reagent generation, test manufacture and the clinical validation required to achieve CE marking and/or FDA510(K) clearance"
Sounds to me like they are pretty well advanced if they are looking at that.
Been reading up on some of the medical journals ( i really should get out more!) and it looks to me that this is bigger than first seems. We appear to be focusing on lung cancer, but as i said earlier, it also acts as a detector for breast, colon, prostate, gall cancers etc. reading some of the papers submitted, it appears that the CIZ1 protein has 22 variants (that is known at present) and has also been associated with gastric cancers, Alzheimers, rheumatoid athritis, and Ewings tumour.
One that stood out was the incidence of brain tumours. Apparently these are only detectable when they have become solid tumour, and there is no cure, with a very poor prognosis. They can't be detected earlier due to "blood brain barrier" If our test can overcome this barrier, and detect the protein before it becomes tumour, just imagine the medical need. The more i read into this research, the better this looks.
Neil

As i understand it, Fujibio were working with a different set of antibodies to Cizzle, which were not compatible with the company's requirements at that time.
Neil

Wideglide, reading the prospectus, there is still some good news here.
There are other companies looking at liquid biopsy diagnostics, but current prototype tests have relied on Western Blot technique.
This technique is expensive, only demonstrates that the test is able to indicate positive result, gives a high percentage of false positive results, and is less reliable when a hospital setting requiring high throughput is required.
The work Cizzle is developing, refines this technique to the stage where it becomes suitable for scaling up to commercial and manufacture. By the sound of things we are ahead of the competition here.
Something to note is the potential for revenue. There are a number of avenues the BOD are exploring. From global licensing of our technology, direct sales, joint ventures, further product line etc.
One thing of note is China. They have the largest increase in lung cancer cases due to the increased level of people taking up smoking (which goes against the rest of the world where most countries are seeing gradual declines) It seems that the BOD are already actively looking at China, and to engage with a Chinese CRO and marketing partner to enter the lung cancer detection market. It just so happens that our Executive Chairman and cancer specialist (Allan Syms) has connections with China having previously held the position of specialist adviser on China to the Department of International Trade.
I am seeing plenty of positives here. Time is the issue.
PS you queried earlier my stage of entry into Bould. Well i was here in the days of Photonstar, and have a fairly significant amount of shares (well into the 10's of millions) so i will be very heavily down at 10p.
Neil
Neil

He hasn't lost penny as far as i can work out.
I said last year that there were reasons he bought photonstar for £1
One being the tax loss that he can use against future profits of his new company. I believe this to be worth over £1million. Also the availability to him of the tax relief in respect of R&D expenditure. I did say that because of a clause in the sale, we were due to a 50% payment from him should he realise that relief. Well he has. To the tune of £107,000.00 to date. So we are due approx £53,500.00 (incidentally this should have been paid to us by April 2020, and which i believe, still has not been paid)
Add to that the fact that he has the option on admission to exercise 7,603,432 shares as the warrants from Peterhouse. At what exercise price? He didn't purchase those at 10p did he? And that is on top of his initial holding.
So you see, as i said back in November i think it was, he couldn't lose.
Neil

Don't think there will be any chance at all of an open offer before listing. It would change the whole prospectus that has already been submitted.
What they should do, once listed, and the dust has settled, is have an open offer with the proviso that a subscription is only open to those who held shares as of 04/10/2019. That would guarantee that only us that have been affected will see a benefit. As a side issue, it would also raise a bit of capital for the company.
Neil
Neil

Rooblertwo
This is the question i submitted:
I, and fellow shareholders welcome the long awaited proposed RTO.
However, we feel that we have not been recognised.
We have supported the proposals and funding of Bould Opportunities prior to suspension, and subsequent de-listing, and have had our money tied up for 19 months. We now find that upon re- listing, the value of our investment has been significantly (for most) reduced. This was to be expected to a point in all honesty, but the issue we have is that anyone buying shares on day 1 of listing will be buying at a much lower price than we did, and will probably sell immediately on a rise.
Whilst i recognise the reason for a placing to achieve a fast capital injection, why did the board not give us, the very people that kept this company alive, a chance to participate in an open offer? This would have at least given us the opportunity to reduce our average price, and made it a little fairer.
Best regards
Neil

Voted in favour, and submitted my question for the webinar
Neil

Tra1 Question 6There are a number of long term shareholders that held shares prior to suspension, and have had their funds tied up without recourse for a substantial time frame. I understand the reason for the placing to get quick capital injection, but why were these shareholders not given the opportunity of an open offer. The general feeling of these shareholders is that we have been put at a significant disadvantage, in that anyone buying shares on relisting will be buying them cheaper than us, the shareholders that supported this company through suspension, de-list and RTO. An open offer would have at least allowed us to reduce our average and make for a fairer result.HrlfcYou may not be convinced yet, but someone was. The placing was made without being underwritten. What this means is that they didn't need the protection of underwriting, as they already have an investor(s) (institution probably at that level) that has made an irrevocable agreement to take the entire issue. Not only that, but they took them at 10p per share. Generally speaking , they command a discount for this. Trust me, they aren't investing £2.2million to see a return of 10 or 20 % This is one of the reasons that we are listing on the main market, and not AIM, as this gives us exposure to the big institutional investors, as i said last year. We are wanting to attract the big boys now. Neil

"Can anyone imagine just how big the market would be for both Prostrate and Breast cancer detection alone!"
Consider this.....
Consultant led referrals for treatment (not ALL cancer i hasten to add) -
Patients waiting over 18 weeks is currently 1,750,000
Patients waiting over 52 weeks is currently 390,000
Total patients on waiting list is currently 4,600,000
Patients on waiting list over 52 weeks is now at a 240 fold increase on 12 months ago mainly as a result of reduced operations because of the pandemic, and is now at a 14 year high.
Chest CT scan costs £400
Breast CT scan costs £600
our test using Cizzle costs approx. £200
The saving to the NHS amounts to approx £62.3 million over 2 years!
And frees up CT scanners for other needs.
Does it get any better?
Neil

At the risk of upsetting some people (which is not the intention i assure you) There is no chance of starting again and getting a better deal. The costs of an abortive result of a no vote, would leave us with little if any money to start again. Even if we could, do you really want to start this process all over again? I cannot understand the statements that the BOD have shafted us. On what basis is that assumption? That they haven't found us a company that will give us £1 a share on day one? 18 months or so ago, we were all but bust. They were tasked with getting us into a company that has prospects of giving shareholders the best return they could. I believe they have. OK it may take time, but what was the alternative? A lot of you had resigned yourselves to the fact that we were not going to come back to market, and you accepted that you lost all your money. Well we are coming back, and you haven't lost your money. You may make a loss, you may make a fortune. That is what this trading shares is all about. I see comments that state " i have lost so much" i will be so down" etc. How do you know? We haven't resumed trading yet. You can't possibly know if the opening price will be up down or what., so those comments are not yet valid. i,m not saying i am happy with the long wait, but i am happy that we haven't gone T**TS up and there is now possibility of a return.The market we are entering is a huge one and if we get it right and prove commerciality of the products, who is to say that the big players in this sector don't come long and take us over? They want small companies like us to develop the process, and then when they see it is a success, they want it.A question was asked as to can liquid biopsy be used in other cancer detection. The answer is yes. Colon, Breast, Prostate, Gall etc.Neil

3 weeks before we are back trading
Neil

PLEASE DO NOT speculate on the target. We are only 3 weeks away from our prayers being answered! To do so at this late stage could be a real threat to the outcome.
Some of you may have worked out who it is, but can i just say keep it to yourselves just a little while longer.
We are about to enter into a segment that according to analysts is worth approx £6billion over the next 3 years. Apologies to PersonA , for not answering you yesterday, but i said last week that i had requested an update, and a response. Yesterday afternoon i made a follow up telephone call, and was awaiting the response. The update we received was better than i thought, having actually given us a date for listing. Well done to all for sticking with it. (not that we had much of a choice!)
We are about to enter a very exciting period. On listing, i believe that it will be very volatile until the dust settles.
No doubt some members here are so relieved when we list, that they will be happy to sell and get their money back. That is a fair position, having waited so long and the frustration felt, and your decision is yours alone to make. Others may see the benefit of holding out for the big reward. My own position will be to hold, as we are in this at such an early stage. Whatever your position is, i wish you all the best.
Neil

Still think i am full of sh*t?
Neil

Evening gents,
Not been on for a while due to personal circumstances.
I have been watching comments over the last few days though, and will offer my own opinion.
The BOD are not the issue here, so please stop having a go at them, Although i will agree that they are somewhat lacking in their duties to keep us informed. A point which i have raised, and requested a response, and will advise further should i be able.
Covid is not the issue either, although it has certainly not helped.
The issue here is the relisting process, which is out of the control of the BOD. They have done their part, and can't progress things further until the issues with the regulatory bodies have concluded. Someone has recently mentioned a certain other company where they are having the very same issues as we are, and seem to be in a news blackout too. They are waiting for something to happen before they can proceed. Remember, it was suggested a while back now, that the "recognised exchange" may not necessarily be AIM, or even a UK exchange for that matter. ( A listing on Nasdaq for example would give rise to certain issues due to shares allocation and ADS's)
I remain 100% confident that once these issues have been put to bed, that we will relist and be in good place.
Probably easier for me to say than it is for others, but there really is no point in getting stressed about the wait. (yes i do realise we are all in different situations) There is nothing we can do about it, and we can't change anything, so stop worrying about something that we can't alter, and just wait for the good news to come.
Best regards and stay safe
Neil

Blimey Roobler, you change your stance quicker than i change my socks!
Hi All
Apologies for not posting, but not been too well over the last 2 weeks, so not logged in.
As my last message, i was hoping that the period following the Christmas holidays wouldn't require a further lockdown, as this could hamper progress.
Hopefully we are far enough advanced now, that it won't make too much of a difference. I wouldn't expect any more updates now until the BOD issue notice of AGM /intended target, which i still believe should come this month. I have had no further communication with anyone since the last one, other than a conversation that leads me to believe that the target is a very exciting prospect.
I know it seems to be never ending, but good things come to those who wait.
As some of you are aware, i am also in EUA (sorry if anyone takes this as a cross ramp, it is just meant to provide point of reference, as to where we are now)
I have been in EUA since before suspension, loss of Nomad, subsequent re-admission, and the notification that we are in a formal sales process. All the time the trolls telling us our money is long gone.
What has this to do with BOU?
Well i am just putting it out there, that these things do take time. Anyone involved in EUA knows this is going to be a VERY VERY special deal.
Same with SYME which i have mentioned to some on here. Most people just do not get it, but it will come.
The point being, i believe that BOU will be a very good outcome, and in all honesty, far better than a lot here think.
Best regards
Neil

Just wanted to wish everyone one here a merry Christmas and a happy New Year.
All the best
Neil

Hi Lovelyboy
Your confidence is only a few %? It should be WAY higher than that ;-)
Come back to that in a minute.
I have had a few questions asked over the last couple of days.
1. Why didn't i join with the telegram group?
The honest answer is, i am not a big fan of private groups like those because a couple of other shares i am in did this, and the messages that were being posted on telegram / premium chat on L2 were not the same as posters were posting on the main BB. Anything i have to say is for the benefit of everybody, not a select few. It also ensures there are no mixed messages.
2. When will we receive another update?
Obviously, i am not part of the BOD so i can't guarantee if and when things will happen. However, i believe that the BOD will wish to save time and money, and i expect that the next news would be the announcement of the deal. Given that this will require the approval of the shareholders, then this would require an AGM. In such a case, i think the BOD will combine the announcements, hence the delay in announcing an AGM. As for timing, the last thing we want is a spike in Covid in week 1-2 of January following the Christmas period. Any further tightening of the rules could inevitably lead to a delay.
3. Do i know who the target is?
If i did, i could not reveal it anyway, as the FCA would be waiting for me to get home tonight! So not for definite, no. but i do have my theories on at least 2 possible candidates.
4. Is the target **** or ********?
This is answered below as per Lovelyboys comment.
5. Am i party to or connected in any way to either Bould, or the intended target?
Definately not. I am just me, an individual shareholder just like the rest of us.

Back to Lovelyboys post.
It is probably obvious to most on here who you are referring to re the target. I will say that it is all to easy to see similarities with other prospects, and make an apparent link. Indeed, approx 12-18 months ago, all the links were there for Couer, and i was pretty sure at the time that it was the target. Having investigated further, i later discounted that theory.
I can make a link to probably 3 companies looking at certain coincidences.
In the case of the one you are concentrating on, you correctly said they published the prospectus. However, this was of the whole company, **** to list on the main market. IF this was the company, then the bit you should be interested in would be a later prospectus/listing of the spin off company, (not happened yet).
Just supposing it was the spin off ********. Would you be happy with that company, (look at what they would bring to the table - a million or so?) or would you be happy with a much better prospect?
Hence my comment you should be WAY more confident than a few %
Neil